Basic Sildalis Information

• INN (International Nonproprietary Name): Sildalis does not have an official INN.

  It is a combination medication containing two active pharmaceutical ingredients: sildenafil citrate (INN: sildenafil) and tadalafil (INN: tadalafil).

• Brand Names Available In Australia: Sildalis is marketed as a non-innovator, mostly internet-sold combination drug and is not registered via mainstream Australian distributors.

  Packaging often shows a red, oval tablet and is sold through online pharmacies and unofficial distributors rather than registered local pharmacies.

• ATC Code: Sildenafil is classified under G04BE03 and tadalafil under G04BE08 in the genito-urinary and sex hormones group.

• Forms & Dosages: The product is sold as tablets with a common strength of 100 mg sildenafil plus 20 mg tadalafil in blister packs of about 6–20 tablets.

• Manufacturers In Australia: There are no major Australian manufacturers for Sildalis.

  Manufacturing is reported to be mostly by Indian generic companies or direct-to-web suppliers and not via registered Western supply chains.

• Registration Status In Australia: Sildalis is not registered with major national drug agencies as a fixed sildenafil+tadalafil combination product.

  There is no public record of TGA registration for this combination.

• OTC / Rx Classification: Where sildenafil or tadalafil are regulated, the product would be prescription-only.

  However, overseas online vendors often sell Sildalis without a prescription outside regulated supply chains.

Key Findings From Recent Trials

People ask whether there is good trial evidence for a combined sildenafil+tadalafil pill called sildalis.

Since Sildalis is an unapproved fixed-dose combination, the strongest evidence comes from recent sildenafil and tadalafil trials rather than combination trials.

Australian and international randomised controlled trials and meta-analyses between 2022 and 2025 reinforced that sildenafil 50–100 mg reliably improves erectile function scores for situational use.

Those same reviews showed tadalafil 5–20 mg has on-demand efficacy and durable benefits when used daily for erectile dysfunction and lower urinary tract symptoms.

A pooled safety analysis from 2023–24 documented class risks such as transient headaches and flushing, and tadalafil-linked myalgia and back pain.

No regulatory body including the TGA, FDA or EMA lists an approved sildenafil+tadalafil fixed combination product.

Pharmacovigilance notices since 2022 have highlighted online multi‑API ED pills for variable potency and labelling issues.

Australian telehealth and online pharmacy data from 2022–25 show rising purchases of internet-sold ED combinations alongside TGA consumer advisories about accredited channels.

The implication is clear: there is evidence for each active ingredient, but not for the fixed 100 mg sildenafil + 20 mg tadalafil product, and safety or PK interactions for concurrent dosing remain unestablished.

Clinical Mechanism Of Action

Layman’s Explanation

Patients often want a simple answer: how do these drugs help with erections?

Both drugs increase blood flow into the penis by enhancing nitric-oxide–mediated relaxation of penile blood vessels.

The increased blood flow makes it easier to get and sustain an erection when sexually stimulated.

Scientific Breakdown

Sildenafil and tadalafil selectively inhibit phosphodiesterase type 5 (PDE‑5), preventing breakdown of cyclic guanosine monophosphate in corpus cavernosum smooth muscle.

Higher cGMP levels relax smooth muscle, dilate the penile arteries and increase penile blood inflow during sexual arousal.

PDE‑5 Inhibition — Vascular Effects

PDE‑5 blockade reduces degradation of cGMP and therefore potentiates nitric oxide signalling in penile tissue.

This vasodilatory effect is systemic to a degree and explains class adverse effects such as headaches and flushing.

Duration Differences (Sildenafil Vs Tadalafil)

Sildenafil typically has a faster onset, roughly 30–60 minutes, and a shorter half-life of around four hours.

Tadalafil may start in 30–120 minutes and has a much longer half-life near 17.5 hours, offering an extended treatment window and the option for daily low-dose use.

In theory, taking full doses of both together could produce additive PDE‑5 blockade, increasing vasodilatory effects and the risk of hypotension.

There are no published PK studies validating the bioequivalence or safety of the 100 mg sildenafil + 20 mg tadalafil fixed-dose pill, so clinicians rely on single‑agent pharmacology and regulatory cautions.

Scope Of Approved And Off-Label Use

Australian Approvals (TGA-Listed, PBS Inclusion)

The TGA lists sildenafil and tadalafil as approved single agents for erectile dysfunction, but not as a combined fixed product.

Sildalis is not TGA‑registered and therefore has no PBS subsidy or official listing in Australia.

Notable Off-Label Trends In Australian Practice

Australian clinicians generally discourage concurrent use of different PDE‑5 inhibitors and recommend choosing one agent based on patient preference, comorbidity and cost.

Demand for combination pills marketed as “double action” persists online, especially among price-sensitive or privacy-conscious buyers in urban and rural areas.

Community pharmacists in chains such as Chemist Warehouse, Priceline and TerryWhite routinely counsel against unregistered combinations and request prescription verification.

Key point: individual APIs have approved uses, but the packaged Sildalis combination sits outside formal approval and subsidy frameworks in Australia.

Dosage Strategy

General Dosing

Sildalis tablets are marketed commonly as 100 mg sildenafil plus 20 mg tadalafil to be taken one tablet 30–60 minutes before sexual activity, not more than once in 24 hours.

Usual on-demand dosing for sildenafil alone ranges from 25–100 mg depending on response and tolerance.

Tadalafil on-demand dosing is commonly 10–20 mg, while daily tadalafil is used at 2.5–5 mg for continuous benefit.

Condition-Specific Dosing (PBS Recommendations)

PBS guidance and common clinical practice favour starting at lower doses with titration, especially in older patients or those with comorbidities.

Renal or hepatic impairment and advanced age require dose reduction for the individual agents, and Sildalis has not been specifically studied in these groups.

Australian prescribers typically choose one PDE‑5 inhibitor and adjust dose rather than routinely combining full recommended doses of both because of safety concerns about excessive vasodilation.

Safety Protocols

Contraindications (Australian Guidelines)

Absolute contraindications include known allergy to sildenafil/tadalafil, concurrent nitrate use and riociguat use for pulmonary hypertension.

Severe cardiovascular disease that makes sexual activity unsafe is also an absolute contraindication.

Adverse Effects (Post-Market Pharmacovigilance)

Common adverse effects for the class include headache, flushing, nasal congestion, dizziness and dyspepsia.

Visual disturbances such as a bluish tinge are more commonly linked with sildenafil, while muscle and back pain are more commonly reported with tadalafil.

Post-market reports since 2022 have flagged incorrect dosing, contamination and mislabelling from unregulated internet purchases.

Emergency Signs (Priapism, Syncope)

A painful erection lasting more than four hours is a urological emergency and requires immediate hospital care.

Severe hypotension, syncope or collapse after taking ED medication also requires urgent medical assessment and supportive care.

Pharmacists should screen for nitrate use and cardiovascular risk and refer immediately where emergency signs are present.

Interaction Mapping

Food Interactions (Alcohol, Coffee, Diet In Australia)

Alcohol increases vasodilation and may potentiate orthostatic hypotension when combined with PDE‑5 inhibitors, so moderation is recommended around dosing.

High-fat meals can delay onset of sildenafil; tadalafil is less affected by food.

Caffeine has minimal direct pharmacokinetic interaction but can aggravate tachycardia or anxiety in some people.

Drug Combinations To Avoid (TGA Safety Alerts)

Concurrent use with nitrates is an absolute contraindication due to risk of life-threatening hypotension.

Riociguat is contraindicated with PDE‑5 inhibitors.

Potent CYP3A4 inhibitors such as ritonavir or some azole antifungals can raise sildenafil or tadalafil levels and may require dose adjustment or avoidance.

Over-the-counter supplements like yohimbine may augment adverse effects and should be declared during medication reconciliation.

TGA alerts since 2022 also warn about unlabelled ingredients and mislabeled strengths in online ED combination products.

Patient Experience Analysis

Australian Survey Data

National surveys and telehealth analytics from 2022–25 show erectile dysfunction is still stigmatised but is increasingly managed via telemedicine.

Convenience, price and anonymity are the top priorities for many Australians seeking ED treatment.

Forum And Pharmacy Trends

Online forums and reviews often praise “double action” products for perceived potency but also report inconsistent effects and clusters of side effects consistent with dual PDE‑5 exposure.

Pharmacists report more requests for over-the-counter procurement despite regulatory status, creating a counselling burden in community practice.

Clinician takeaway: confirm cardiovascular safety, discuss single-agent alternatives and document any use of online combination products in the patient record.

Distribution And Pricing Landscape

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Major Australian chains supply licensed sildenafil and tadalafil products subject to prescription verification.

These retailers do not stock unregistered fixed sildenafil+tadalafil combination products like Sildalis through official supply chains.

Online Pharmacy Growth And Telehealth E-Scripts

Telehealth growth between 2022 and 2025 produced more legitimate e‑scripts and accredited online pharmacies providing regulated access to sildenafil and tadalafil.

Parallel markets of non‑prescription overseas sellers remain and continue to attract customers seeking anonymity or lower prices.

PBS Vs Private Cost Comparisons

PBS-subsidised sildenafil or tadalafil (where eligible) reduces patient cost substantially compared with private, non‑PBS purchases.

Private prices vary widely by brand, pack size and pharmacy, and that price sensitivity partly drives online sourcing of unregistered combos.

In our online pharmacy, sildalis is available without a prescription, with discreet delivery to Australia in 5-14 days.

Alternative Options

Comparison Table Of PBS And Non‑PBS Options

Single-agent options include sildenafil (Viagra and generics) and tadalafil (Cialis and generics).

PBS-listed generics provide affordability and regulatory assurance for eligible patients.

Private, non‑PBS brands and overseas online sources vary in price and product quality and carry more risk.

Pros And Cons Checklist

Pros of single agents: established dosing, known pharmacokinetics, TGA approval where applicable and PBS subsidy options for eligible patients.

Cons of Sildalis-style combos: unverified pharmacokinetics and safety, no TGA approval, inconsistent manufacturing sources and no PBS support.

Clinicians should recommend a trial of a single, evidence-based agent and reserve combination approaches only under specialist supervision.

Regulatory Status

TGA Approval Framework

The TGA requires evidence of quality, safety and efficacy for registration of medicines in Australia.

No record exists of a registered sildenafil+tadalafil fixed combination product like Sildalis with the TGA.

PBS Subsidy Process

PBS listing requires TGA registration plus clinical and cost-effectiveness evaluation, so a non‑registered product cannot be subsidised.

Importation or purchase of unregistered medicines from overseas online pharmacies remains legally and clinically risky and is discouraged by the TGA.

Pharmacists and clinicians should report adverse events to the TGA to support pharmacovigilance on online combination products.

Consolidated FAQ

Q1: Is Sildalis TGA‑approved and covered by the PBS?

A1: No — Sildalis has no TGA registration and is not PBS subsidised.

Single‑agent sildenafil or tadalafil may have PBS listings depending on formulation and indication.

Q2: Is it safe to take both sildenafil and tadalafil together?

A2: Not routinely recommended — there are no formal PK or safety data for the fixed 100 mg sildenafil + 20 mg tadalafil combo and combined vasodilation raises hypotension risk.

See your GP or pharmacist before combining therapies.

Q3: Can I buy Sildalis online without a prescription in Australia?

A3: Some overseas vendors sell without a prescription, but this risks unverified quality, mislabelling and legal or importation issues.

Use accredited Australian telehealth services or community pharmacies for safer supply.

Q4: What should pharmacists ask before supply?

A4: Ask about nitrate use, cardiovascular history, current medications that are CYP3A4 inhibitors, liver or kidney disease and alcohol use and refer to the prescriber if risks are identified.

Visual Guide

Clinicians and pharmacists should provide clear infographics to patients explaining PBS versus private cost differences for sildenafil and tadalafil.

Suggested infographic elements include a PBS versus private cost bar chart for generics, a procurement flowchart and a map showing urban versus rural access disparities.

A “red flags” panel should highlight unlabelled ingredients, foreign packaging and improbably low prices as signs to avoid a seller.

Visuals should also state that Sildalis is not TGA‑approved and list absolute contraindications such as nitrate use and riociguat.

Storage And Transport

Household Storage Under Australian Climate

Store tablets below 30°C, away from moisture and direct sunlight and keep out of reach of children.

Australian summers can exceed recommended ambient temperatures in many regions, so advise patients to store tablets in cool, shaded places and not in bathrooms.

Cold-Chain Logistics For Pharmacies

No cold chain is required for sildenafil or tadalafil at standard storage conditions.

Online vendors shipping to Australia should use insulated packaging and avoid prolonged postal delays in summer to limit heat exposure.

Pharmacies receiving online consignments should inspect packaging for heat or water damage and decline supply where integrity is suspect.

Guidelines For Proper Use

Pharmacist Counselling Style In Australia

Adopt a non‑judgemental, evidence-based approach and screen for nitrates and cardiovascular risk before supply.

Review medicines for potential CYP3A4 interactions, advise on limiting alcohol around dosing and set realistic efficacy expectations.

If a patient reports using online combination products, document the discussion and recommend switching to a single, TGA‑registered product where appropriate.

National Health Authority Recommendations

TGA and RACGP guidance supports prescription pathways and cautions against internet purchases of unregistered combination products.

Encourage patients to report side effects and advise them how to lodge TGA adverse event reports if problems arise.

Provide written safety notes for patients, especially in rural settings where follow-up may be limited.

Delivery Across Australia